HAIFA, Israel — Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, announced today that it has entered into a strategic collaboration with Thermo Fisher Scientific to advance fundamental knowledge of cell therapy industrialization and to improve quality control of the end-to-end supply chain. The collaboration combines Thermo Fisher’s experience in cell therapy […]
ScreenIn3D (Glasgow, UK) is a new joint venture company set up by AMSBIO and the University of Strathclyde exploiting the latest advances in microfluidics and 3D culture to develop a novel microfluidic screening platform. The unique combination of microfluidic lab-on-a-chip technology with physiologically relevant 3D spheroids is designed to make drug discovery more closely relevant […]
Zurich / Glattbrugg | Cytosurge AG, a Swiss company that develops, manufactures and distributes scientific high-precision nanotechnology instruments and robotic systems based on its patented FluidFM® technology, and Bruker Corporation, one of the world’s leading analytical instrumentation companies, have entered into a new partnership. Thanks to this Premium partnership, researchers can combine the femtoliters scale fluid control […]
ALAMEDA, Calif.–BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that it has been awarded a grant of $743,345 from the Small Business Innovation Research (SBIR) program of the National Institutes of Health (NIH). This award constitutes the second-year funding of a $1.6 million SBIR grant to advance BioTime’s innovative, next generation retinal restoration program addressing advanced retinal diseases […]
Since the groundbreaking discovery of human induced pluripotent stem cells (hiPSCs) by Shinya Yamanaka in 2006, the use of pluripotent stem cells (PSCs) has experienced a boom. Due to their extensive in vitro self-renewal properties and their ability to differentiate into many different cell types, PSCs, and especially hiPSCs, offer exciting promises in a wide […]
Symcel appoints two new board members to bolster R&D business growth and expansion into the clinical diagnostics market L: Stefan Löfås, R: Erik Walldén Symcel – the company behind the revolutionary cell-based assay tool for real-time cell metabolism measurements, the calScreener™ – has announced the appointment of two new highly experienced board members; Erik Walldén and […]
Sysmex Corporation (HQ: Kobe, Japan: Chairman and CEO: Hisashi Ietsugu), the Foundation for Biomedical Research and Innovation at Kobe1 (Location: Kobe, Japan; President: Tasuku Honjo) and Kyoto University (Location: Kyoto, Japan; President: Juichi Yamagiwa) have begun joint research related to the Drug Discovery Innovation Program2: Developing Technologies for Diagnosing Immunological Diseases, which the Foundation is promoting. […]
Berkeley Lights and ChemPartner Collaborate on Accelerating Antibody Discovery Emeryville, Calif. Berkeley Lights, Inc. (BLI), a leader in digital cell biology, announced today that it has entered into a collaboration with ChemPartner Co., Ltd. (ChemPartner) focused on accelerating ChemPartner’s monoclonal antibody (mAb) discovery workflow utilizing the Beacon®Optofluidic platform. The goal is to expand ChemPartner’s antibody discovery […]
Program will Aim to Further Characterize the Functional Impact of Nektar Immunotherapies BRANFORD, Conn. — IsoPlexis Corporation (IsoPlexis), a privately held life sciences company at the forefront of single-cell analytics technology, announced today its collaboration with Nektar Therapeutics. The collaboration is focused on further defining the functional impact of NKTR-214 in the clinic, at the single-cell level, […]
S2 Genomics will develop the Singulator™ system for automated preparation of single cells or nuclei from solid tissue samples LIVERMORE, Calif.–S2 Genomics, Inc. has received a $280,000 Phase I STTR grant (1 R41 HG010129-01) from the National Institutes of Health’s National Human Genome Research Institute to develop the Singulator™ system for automated preparation of single […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
